Innovative Journal of Pediatrics
The Scientific Journal of Growth & Development Research Center
Image Credit:Inn J Pediatr
Outline
The Effect of Positive Family History of Autoimmunity in Juvenile Idiopathic Arthritis Characteristics; a Case Control Study
Authors
Abstract
Objective: To compare Juvenile Idiopathic Arthritis (JIA) patients with and without family history of autoimmune disease with respect to clinical features and laboratory data. Methods: Sixteen JIA patients with family history of autoimmune disease were identified during study, 32 patients were chosen for comparative group from referred patients to the rheumatology clinic according to the date of referral. Two groups were compared with respect to age of onset, sex, subtype, disease activity, duration of active disease and laboratory variables. Findings: The age of onset was significantly lower in JIA patients with family history of autoimmunity (4.7 years vs. 7.0 years; P=0.02), polyarthicular subtype was more frequent in patients with positive family history (50% vs.25%; P=0.04) most of JIA patients with positive family history were in the active phase at the time of study (64% vs 25%; P=0.02) and had a longer duration of active disease (21.0 months vs 12.3 months; P=0.04). Patients with positive family history had more positive ANA (43.5%% vs 12.5%; P=0.01) and also more positive ADA (75% vs 20.8%; P=0.002). Two groups were similar according to sex, and other laboratory variables. Conclusion: JIA patients with family history of autoimmune disease seem to have a more severe disease than patients without such family history, they are younger at the onset, and have mostly poyarthicular subtype. They also have more ANA and ADA positivity. These findings are different from familial JIA case-control studies according to active disease duration, subtype, and ANA positivity.
Highlights
References
- 1.References are available on the PDF.
Copyright
© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Interleukin-1 as a Key Factor in the Development of Inflammatory Diseases
Farivar S, Hassani M, Shiari R. Interleukin-1 as a Key Factor in the Development of Inflammatory Diseases. Arch Pediatr Infect Dis. 2014;2(4):e18177. doi: https://doi.org/10.5812/pedinfect.18177
Clinical Characteristics and Ocular Complications of Uveitis in Juvenile Idiopathic Arthritis: A Cross-sectional Study from a Tertiary Pediatric Center
Malek A, Hosseini SM, Hajipour S, Vahedi M. Clinical Characteristics and Ocular Complications of Uveitis in Juvenile Idiopathic Arthritis: A Cross-sectional Study from a Tertiary Pediatric Center. Inn J Pediatr. 2026;36(4):e165108. doi: https://doi.org/10.5812/ijpediatr-165108
The role of the history of coronary heart disease among second degree relatives for predicting coronary artery disease
Alipour Parsa S, Saemifar F, Khaheshi I, Naderian M. The role of the history of coronary heart disease among second degree relatives for predicting coronary artery disease. Int J Cardiovasc Pract. 2016;1(2):e130037. doi: https://doi.org/10.20286/ijcp-010202
Prevalence of autoimmune diseases in MS patients and their relatives in Kerman
Sadighi B, Dalily M. Prevalence of autoimmune diseases in MS patients and their relatives in Kerman. J Inflamm Dis. 2024;8(2):e155041. doi:
Growth Failure in a Series of Iranian Patients with Juvenile Idiopathic Arthritis
Aghamahdi F, Setoodeh A, Ziaee V, Rabbani A. Growth Failure in a Series of Iranian Patients with Juvenile Idiopathic Arthritis. Inn J Pediatr. 2018;28(3):e11156. doi: https://doi.org/10.5812/ijp.11156
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 3
Last Update: 1 week ago
- Scopus by Title (Ref): 3
Last Update: 1 week ago
- CrossRef: 0
Last Update: 4 hours ago
- OpenAlex: 0
Last Update: 7 hours ago
- OpenCitations: 0
Last Update: 5 days ago